Pam Belluck / nytimes - A study of more than 5,000 pages of agency documents on mifepristone over 12 years found that agency leaders almost always followed the evidence-based recommendations of scientists.
#healthcare #pharmaceuticals #publichealth #governmentpolicy #drugdevelopment #fda
Saturday, January 17, 2026, 8:21 am / permalink 18126 / 5 stories in 1 month
EPA proposes rollback on ethylene oxide sterilizer emissions (6 min)
Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.